| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |